Found in our work association of the FDPS gene with pronounced response to BPs treatment is not unexpected, since many previous studies on other populations have shown that various polymorphic variants of this gene, as well as the GGPS1 gene determine the effectiveness of osteoporosis treatment with various BPs [14–16,29]. The gene discussed is GGPS1; the disease is Bartsocas-Papas syndrome 1.